Jennifer Lachey
Hoofd Techniek/Wetenschap/O&O bij KEROS THERAPEUTICS, INC.
Actieve functies van Jennifer Lachey
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
KEROS THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2019 | - |
Corporate Officer/Principal | 01-07-2016 | 01-06-2019 |
Loopbaan van Jennifer Lachey
Eerdere bekende functies van Jennifer Lachey
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SERES THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-03-2015 | 01-07-2016 |
EMBER THERAPEUTICS, INC. | Corporate Officer/Principal | 01-07-2012 | 01-01-2015 |
ACCELERON PHARMA INC. | Corporate Officer/Principal | 01-01-2008 | 01-07-2012 |
Opleiding van Jennifer Lachey
Indiana University | Undergraduate Degree |
University of Cincinnati (Ohio) | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Director/Board Member | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
KEROS THERAPEUTICS, INC. | Health Technology |
SERES THERAPEUTICS, INC. | Health Technology |
EMBER THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis on June 13, 2003 and is headquartered in Rahway, NJ. | Health Technology |
- Beurs
- Insiders
- Jennifer Lachey
- Ervaring